Motif Bio plc

General Information
Business:

(Note – public offering: “Our ordinary shares are currently listed on the AIM Market of the London Stock Exchange, or AIM, under the symbol “MTFB.”) 

We are a clinical stage biopharmaceutical company engaged in the research and development of novel antibiotics designed to be effective against serious and life-threatening infections in hospitalized patients caused by multi-drug resistant bacteria. The discovery of new antibiotics has not kept pace with the increasing incidence of resistant, difficult-to-treat bacteria. One of the biggest threats of antibiotic resistance is from MRSA, a leading cause of hospital-acquired infections and a growing cause of infections in healthy people in the general community.

Industry: PHARMACEUTICAL PREPARATIONS
Employees: 4
Founded: 2009
Contact Information
Address 125 Park Avenue 25th Floor, Suite 2622, New York, NY 10011, US
Phone Number (212) 210-6248
Web Address http://www.motifbio.com
View Prospectus: Motif Bio plc
Financial Information
Market Cap $89.1mil
Revenues $0.0 mil (last 12 months)
Net Income $-20.8 mil (last 12 months)
IPO Profile
Symbol MTFB
Exchange NASDAQ
Shares (millions): 2.4
Price range $6.98 - $6.98
Est. $ Volume $16.8 mil
Manager / Joint Managers H.C. Wainwright & Co.
CO-Managers -
Expected To Trade: 11/18/2016
Status:
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change